Literature DB >> 21411850

Anakinra for the inflammatory complications of chronic granulomatous disease.

F L van de Veerdonk, M G Netea, C A Dinarello, J W M van der Meer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21411850

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


× No keyword cloud information.
  16 in total

Review 1.  Evasion of inflammasome activation by microbial pathogens.

Authors:  Tyler K Ulland; Polly J Ferguson; Fayyaz S Sutterwala
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 2.  An Update on the Use of Immunomodulators in Primary Immunodeficiencies.

Authors:  Pandiarajan Vignesh; Amit Rawat; Surjit Singh
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 3.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

Review 4.  Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Rheumatology (Oxford)       Date:  2015-07-23       Impact factor: 7.580

5.  Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.

Authors:  Rebecca A Marsh; Jennifer W Leiding; Brent R Logan; Linda M Griffith; Danielle E Arnold; Elie Haddad; E Liana Falcone; Ziyan Yin; Kadam Patel; Erin Arbuckle; Jack J Bleesing; Kathleen E Sullivan; Jennifer Heimall; Lauri M Burroughs; Suzanne Skoda-Smith; Shanmuganathan Chandrakasan; Lolie C Yu; Benjamin R Oshrine; Geoffrey D E Cuvelier; Monica S Thakar; Karin Chen; Pierre Teira; Shalini Shenoy; Rachel Phelan; Lisa R Forbes; Deepak Chellapandian; Blachy J Dávila Saldaña; Ami J Shah; Katja G Weinacht; Avni Joshi; Farid Boulad; Troy C Quigg; Christopher C Dvorak; Debi Grossman; Troy Torgerson; Pamela Graham; Vinod Prasad; Alan Knutsen; Hey Chong; Holly Miller; M Teresa de la Morena; Kenneth DeSantes; Morton J Cowan; Luigi D Notarangelo; Donald B Kohn; Elizabeth Stenger; Sung-Yun Pai; John M Routes; Jennifer M Puck; Neena Kapoor; Michael A Pulsipher; Harry L Malech; Suhag Parikh; Elizabeth M Kang
Journal:  J Clin Immunol       Date:  2019-08-02       Impact factor: 8.317

Review 6.  Overview of the IL-1 family in innate inflammation and acquired immunity.

Authors:  Charles A Dinarello
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

7.  Opposing Effects of IL-1Ra and IL-36Ra on Innate Immune Response to Pseudomonas aeruginosa Infection in C57BL/6 Mouse Corneas.

Authors:  Nan Gao; Rao Me; Chenyang Dai; Berhane Seyoum; Fu-Shin X Yu
Journal:  J Immunol       Date:  2018-06-11       Impact factor: 5.422

Review 8.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130

Review 9.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.

Authors:  Charles A Dinarello; Anna Simon; Jos W M van der Meer
Journal:  Nat Rev Drug Discov       Date:  2012-08       Impact factor: 84.694

10.  IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.

Authors:  Antonella de Luca; Sanne P Smeekens; Andrea Casagrande; Rossana Iannitti; Kara L Conway; Mark S Gresnigt; Jakob Begun; Theo S Plantinga; Leo A B Joosten; Jos W M van der Meer; Georgios Chamilos; Mihai G Netea; Ramnik J Xavier; Charles A Dinarello; Luigina Romani; Frank L van de Veerdonk
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.